SPOTLIGHT -
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
sNDA Submitted: Spravato as Monotherapy for Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Suicidality and Suicide Prevention Following Brain Injury
Blue Light, Depression, and Bipolar Disorder
Which Antidepressant Causes the Least Amount of Weight Gain?
The Week in Review: June 24-28